Sab Biotherapeutics, Inc. · NASDAQ:SABS

Caligan Partners LP reported a 10.40% stake in Sab Biotherapeutics, Inc. (Schedule 13G)

Event Mar 31, 2026 · Filed May 15, 2026

Caligan Partners LP reported a 10.40% stake in Sab Biotherapeutics, Inc., 7,697,207 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G).

Stake
10.40%
Shares
7,697,207
Intent
Passive
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
Caligan Partners LP10.40%7,697,207
JOHNSON DAVID EDWARD10.40%7,967,207

Source

View original at SEC

Related